A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Treatment Gaining Traction Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these profiles privately for source information, while also receiving promotional offers.
Thriving Commerce on Social Networks
Separately, a flourishing market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing customers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Professionals Express Worries
Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.
Some professionals said the popularity for retatrutide could be connected to the rising cost of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer laws, potentially leading to penalties, legal action or prison.
Service Response and Material Removal
According to TikTok, the service has removed problematic material and banned related keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and investing in strengthening compliance measures.
Digital Marketplace Activities
Investigations also discovered groups with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with numerous of users, filled with photos of slimming results, glowing reviews and step-by-step guides for mixing or administering at home.
After minutes of joining one group, a vendor posted contact information, where most purchases occur. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.
Product Information and Costs
Within these groups, posts show black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A representative for the messaging service said it actively moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her team has previously seen patients harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject users to potentially serious medical dangers”.
